Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prolonged bisphosphonate release after treatment in children.

× No keyword cloud information.

55 in total

1. On the pharmacological evaluation of bisphosphonates in humans.

Authors: Serge Cremers; Frank Hal Ebetino; Roger Phipps
Journal: Bone Date: 2020-06-27 Impact factor: 4.398

2. Skeletal imaging effects of pamidronate therapy in osteosarcoma patients.

Authors: Anita P Price; Sara J Abramson; Sinchun Hwang; Alexander Chou; Roger Bartolotta; Paul Meyers; Douglas S Katz
Journal: Pediatr Radiol Date: 2010-10-30

3. Zoledronate and Raloxifene combination therapy enhances material and mechanical properties of diseased mouse bone.

Authors: Katherine M Powell; Cayla Skaggs; Alexis Pulliam; Alycia Berman; Matthew R Allen; Joseph M Wallace
Journal: Bone Date: 2019-06-21 Impact factor: 4.398

4. Removal of matrix-bound zoledronate prevents post-extraction osteonecrosis of the jaw by rescuing osteoclast function.

Authors: Ranya Elsayed; Pheba Abraham; Mohamed E Awad; Zoya Kurago; Balasudha Baladhandayutham; Gary M Whitford; David H Pashley; Charles E McKenna; Mohammed E Elsalanty
Journal: Bone Date: 2018-02-09 Impact factor: 4.398

Review 5. Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease.

Authors: Peter K Wong; Gelsomina L Borromeo; John D Wark
Journal: Rheumatol Int Date: 2013-05-08 Impact factor: 2.631

6. Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study.

Authors: A Sokal; E Elefant; T Leturcq; D Beghin; X Mariette; R Seror
Journal: Osteoporos Int Date: 2018-08-31 Impact factor: 4.507

7. Approach to the child with fractures.

Authors: Alison M Boyce; Rachel I Gafni
Journal: J Clin Endocrinol Metab Date: 2011-07 Impact factor: 5.958

8. Low Dose of Bisphosphonate Enhances Sclerostin Antibody-Induced Trabecular Bone Mass Gains in Brtl/+ Osteogenesis Imperfecta Mouse Model.

Authors: Diana Olvera; Rachel Stolzenfeld; Joan C Marini; Michelle S Caird; Kenneth M Kozloff
Journal: J Bone Miner Res Date: 2018-05-07 Impact factor: 6.741

9. Complications of pamidronate therapy in paediatric osteoporosis.

Authors: Sanjay K Chilbule; Vrisha Madhuri
Journal: J Child Orthop Date: 2012-01-29 Impact factor: 1.548

10. Osteoporosis in children: pediatric and pediatric rheumatology perspective: a review.

Authors: Yosef Uziel; Eyal Zifman; Philip J Hashkes
Journal: Pediatr Rheumatol Online J Date: 2009-10-16 Impact factor: 3.054